{
  "slug": "ucsf-weill-institute-for-neurosciences",
  "name": "ucsf-weill-institute-for-neurosciences",
  "description": "The UCSF Weill Institute for Neurosciences is a leading research institute dedicated to solving challenging problems of the human brain and reducing suffering from neurologic and psychiatric diseases. It focuses on groundbreaking research into a wide array of conditions, including brain aneurysms, Alzheimer's, epilepsy, Parkinson's, migraines, depression, anxiety, multiple sclerosis, glioblastoma, traumatic brain injury, and dementia.",
  "url": "https://optimly.ai/brand/ucsf-weill-institute-for-neurosciences",
  "websiteUrl": "https://weill.ucsf.edu/",
  "logoUrl": "https://logo.clearbit.com/weill.ucsf.edu",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-10T13:40:41.800Z",
  "verifiedVitals": {
    "website": "https://weill.ucsf.edu",
    "headquarters": "San Francisco, CA",
    "pricing_model": "Primarily funded through grants, philanthropy, and institutional support from UCSF. Its 'products' are intellectual property and public health advancements rather than commercially priced goods for end-users.",
    "core_products": "Research discoveries, medical advancements, diagnostic tools, therapeutic strategies, academic publications, and training programs for future neuroscientists and clinicians.",
    "key_differentiator": "A comprehensive focus on a wide array of neurological and psychiatric diseases, integration of cutting-edge technologies including AI in research and clinical applications, strong emphasis on translating discoveries into clinical practice, and its affiliation with a world-renowned academic medical center (UCSF).",
    "target_markets": "Global scientific and medical community, patients and families affected by neurological and psychiatric disorders, funding bodies (e.g., NIH, philanthropic organizations), and biotechnology/pharmaceutical industry partners.",
    "subcategory": "Neuroscience Research Institute"
  },
  "intentTags": {
    "problemIntents": [
      "Brain aneurysms",
      "Alzheimer's cognitive decline",
      "Epileptic 'Brain Blips'",
      "Parkinson's disease",
      "Episodic neurological disorders",
      "Depression and anxiety",
      "Migraines",
      "Glioblastoma retreatment",
      "Early detection of Multiple Sclerosis",
      "Meningioma surveillance",
      "Precision of brain tumor surgery",
      "Drug-resistant epilepsy",
      "Overactive bladder",
      "Solid tumors",
      "Neurodegenerative diseases",
      "ALS and complex diseases",
      "Periprocedural stroke detection",
      "Chronic primary pain",
      "Dementia diagnosis and monitoring",
      "Traumatic brain injury (TBI) diagnosis and prognostication",
      "Depression screening",
      "Alpha-synuclein aggregates in Parkinson's",
      "Neurologic infection",
      "Human herpesviruses",
      "Glioma therapy delivery",
      "Autoimmune diseases",
      "Vocal affect recognition deficits in autism",
      "Post-COVID cognitive changes",
      "MOG antibody disease",
      "Adolescent depression",
      "Cellular migration in developing brain",
      "Diabetic neuropathy",
      "Cognitive impairment after anesthesia and surgery"
    ],
    "solutionIntents": [
      "Predicting aneurysm ruptures",
      "Detecting early cognitive decline",
      "Understanding epileptic mechanisms",
      "Developing Parkinson's therapies",
      "Identifying genetic treatments",
      "Mapping circuits for psychiatric disorders",
      "Root cause analysis for migraines",
      "Biomarker validation",
      "Optimizing diagnostics",
      "AI platform clinical deployment",
      "AI-guided brain mapping",
      "Personalized focused ultrasound stimulation",
      "Minimally invasive neurosurgery",
      "Patient-friendly wearables",
      "Immunotherapy advancement",
      "Blood-brain-barrier-penetrable treatments",
      "Digital health platforms",
      "Improved stroke detection systems",
      "Biomarkers for pain diagnosis",
      "Speech-based diagnostic tools",
      "Targeted gene delivery",
      "Multi-agent AI diagnosis systems",
      "Correcting protein trafficking",
      "Personalized depression screening",
      "Blocking toxic protein aggregates",
      "Novel diagnostics",
      "MRI similarity search engines",
      "Adaptive deep brain stimulation",
      "Antiviral treatments",
      "Effective therapy delivery systems",
      "Targeted autoimmune treatments",
      "Minimally invasive neuromodulation",
      "Identifying autism barriers",
      "Unraveling biological signatures",
      "Spinal cord stimulation optimization",
      "Establishing disease biomarkers",
      "Assessing meditation benefits",
      "Mapping cellular migration",
      "Deciphering disease origins",
      "Predicting cognitive impairment"
    ],
    "evaluationIntents": [
      "Understanding mechanisms",
      "Detecting conditions",
      "Identifying pathways",
      "Validating biomarkers",
      "Optimizing processes",
      "Improving outcomes",
      "Assessing changes",
      "Mapping biological structures",
      "Evaluating treatments"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1786545353152
}